Literature DB >> 18285775

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation.

Qizhi Tang1, Jeffrey A Bluestone.   

Abstract

The function of regulatory T cells (T(reg) cells) has been attributed to a growing number of diverse pathways, molecules and processes. Seemingly contradictory conclusions regarding the mechanisms underlying T(reg) cell suppressive activity have revitalized skeptics in the field who challenge the core validity of the idea of T(reg) cells as central immune regulators. However, we note that a consensus may be emerging from the data: that multiple T(reg) cell functions act either directly or indirectly at the site of antigen presentation to create a regulatory milieu that promotes bystander suppression and infectious tolerance. Thus, the versatility and adaptability of the Foxp3+ T(reg) cells may in fact be the best argument that these cells are 'multitalented masters of immune regulation'.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18285775      PMCID: PMC3075612          DOI: 10.1038/ni1572

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  84 in total

1.  A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.

Authors:  Laura Strauss; Christoph Bergmann; Miroslaw Szczepanski; William Gooding; Jonas T Johnson; Theresa L Whiteside
Journal:  Clin Cancer Res       Date:  2007-08-01       Impact factor: 12.531

2.  Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death.

Authors:  Marta A Toscano; Germán A Bianco; Juan M Ilarregui; Diego O Croci; Jorge Correale; Joseph D Hernandez; Norberto W Zwirner; Francoise Poirier; Eleanor M Riley; Linda G Baum; Gabriel A Rabinovich
Journal:  Nat Immunol       Date:  2007-06-24       Impact factor: 25.606

3.  Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice.

Authors:  Mark A Travis; Boris Reizis; Andrew C Melton; Emma Masteller; Qizhi Tang; John M Proctor; Yanli Wang; Xin Bernstein; Xiaozhu Huang; Louis F Reichardt; Jeffrey A Bluestone; Dean Sheppard
Journal:  Nature       Date:  2007-08-12       Impact factor: 49.962

4.  T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation.

Authors:  Ming O Li; Yisong Y Wan; Richard A Flavell
Journal:  Immunity       Date:  2007-05-03       Impact factor: 31.745

5.  O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1.

Authors:  Hector F Valenzuela; Karen E Pace; Paula V Cabrera; Rachel White; Katja Porvari; Helena Kaija; Pirkko Vihko; Linda G Baum
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

6.  Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function.

Authors:  Jan Kubach; Petra Lutter; Tobias Bopp; Sabine Stoll; Christian Becker; Eva Huter; Christoph Richter; Petra Weingarten; Tobias Warger; Jürgen Knop; Stefan Müllner; John Wijdenes; Hansjörg Schild; Edgar Schmitt; Helmut Jonuleit
Journal:  Blood       Date:  2007-05-14       Impact factor: 22.113

Review 7.  Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells.

Authors:  Peter Terness; Marinos Kallikourdis; Alexander G Betz; Gabriel A Rabinovich; Shigeru Saito; David A Clark
Journal:  Am J Reprod Immunol       Date:  2007-09       Impact factor: 3.886

8.  A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism.

Authors:  Janine L Coombes; Karima R R Siddiqui; Carolina V Arancibia-Cárcamo; Jason Hall; Cheng-Ming Sun; Yasmine Belkaid; Fiona Powrie
Journal:  J Exp Med       Date:  2007-07-09       Impact factor: 14.307

9.  Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression.

Authors:  Tobias Bopp; Christian Becker; Matthias Klein; Stefan Klein-Hessling; Alois Palmetshofer; Edgar Serfling; Valeska Heib; Marc Becker; Jan Kubach; Steffen Schmitt; Sabine Stoll; Hansjörg Schild; Martin S Staege; Michael Stassen; Helmut Jonuleit; Edgar Schmitt
Journal:  J Exp Med       Date:  2007-05-14       Impact factor: 14.307

10.  Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.

Authors:  Silvia Deaglio; Karen M Dwyer; Wenda Gao; David Friedman; Anny Usheva; Anna Erat; Jiang-Fan Chen; Keiichii Enjyoji; Joel Linden; Mohamed Oukka; Vijay K Kuchroo; Terry B Strom; Simon C Robson
Journal:  J Exp Med       Date:  2007-05-14       Impact factor: 14.307

View more
  416 in total

Review 1.  Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology.

Authors:  Nobuyoshi Hiraoka
Journal:  Int J Clin Oncol       Date:  2010-10-06       Impact factor: 3.402

2.  T regulatory cells participate in the control of germinal centre reactions.

Authors:  Carla-Maria Alexander; Lorraine T Tygrett; Alexander W Boyden; Kristy L Wolniak; Kevin L Legge; Thomas J Waldschmidt
Journal:  Immunology       Date:  2011-06-03       Impact factor: 7.397

3.  Mechanisms of immune tolerance relevant to food allergy.

Authors:  Brian P Vickery; Amy M Scurlock; Stacie M Jones; A Wesley Burks
Journal:  J Allergy Clin Immunol       Date:  2011-01-31       Impact factor: 10.793

4.  Reversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-12.

Authors:  Mariana Malvicini; Mariana Ingolotti; Flavia Piccioni; Mariana Garcia; Juan Bayo; Catalina Atorrasagasti; Laura Alaniz; Jorge B Aquino; Jaime A Espinoza; Manuel Gidekel; O Graciela Scharovsky; Pablo Matar; Guillermo Mazzolini
Journal:  Mol Oncol       Date:  2011-04-05       Impact factor: 6.603

5.  Transgenic expression of interferon-γ in mouse stomach leads to inflammation, metaplasia, and dysplasia.

Authors:  Li-Jyun Syu; Mohamad El-Zaatari; Kathryn A Eaton; Zhiping Liu; Manas Tetarbe; Theresa M Keeley; Joanna Pero; Jennifer Ferris; Dawn Wilbert; Ashley Kaatz; Xinlei Zheng; Xiotan Qiao; Marina Grachtchouk; Deborah L Gumucio; Juanita L Merchant; Linda C Samuelson; Andrzej A Dlugosz
Journal:  Am J Pathol       Date:  2012-10-01       Impact factor: 4.307

6.  The Critical Role of TGF-beta1 in the Development of Induced Foxp3+ Regulatory T Cells.

Authors:  Song Guo Zheng
Journal:  Int J Clin Exp Med       Date:  2008-06-10

7.  Analysis of adhesion molecules, target cells, and role of IL-2 in human FOXP3+ regulatory T cell suppressor function.

Authors:  Dat Q Tran; Deborah D Glass; Gulbu Uzel; Dirk A Darnell; Christine Spalding; Steven M Holland; Ethan M Shevach
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  NF-kappa B1 p105 regulates T cell homeostasis and prevents chronic inflammation.

Authors:  Mikyoung Chang; Andrew J Lee; Leo Fitzpatrick; Minying Zhang; Shao-Cong Sun
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 9.  Targeting Type 1 Diabetes: Selective Approaches for New Therapies.

Authors:  Daniel F Sheehy; Sean P Quinnell; Arturo J Vegas
Journal:  Biochemistry       Date:  2019-01-17       Impact factor: 3.162

10.  T regulatory cells distinguish two types of primary hypophysitis.

Authors:  S Mirocha; R B Elagin; S Salamat; J C Jaume
Journal:  Clin Exp Immunol       Date:  2008-12-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.